Advanced oxidation protein products in nondiabetic end stage renal disease patients on maintenance haemodialysis

References

• Stenvinkel P, Carrero JJ, Axelsson J, et al. Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle? Clin J Am Soc Nephrol. 2008;3:505–521.
   PubMed Web of Science ®Google Scholar
• Carrero JJ, Stenvinkel P. Inflammation in end-stage renal disease – what have we learned in 10 years? Semin Dial. 2010;23:498–509.
   PubMed Web of Science ®Google Scholar
• Akchurin OM, Kaskel F. Update on inflammation in chronic kidney disease. Blood Purif. 2015;39:84–92.
   PubMed Web of Science ®Google Scholar
• Agarwal R, Vasavada N, Sachs NG, et al. Oxidative stress and renal injury with intravenous iron in patients with chronic kidney disease. Kidney Int. 2004;65:2279–2289.
   PubMed Web of Science ®Google Scholar
• Pavone B, Sirolli V, Giardinelli A, et al. Plasma protein carbonylation in chronic uremia. JN. 2011;24:453–464.
   Google Scholar
• Albarello K, dos Santos GA, Bochi GV, et al. Ischemia modified albumin and carbonyl protein as potential biomarkers of protein oxidation in hemodialysis. Clin Biochem. 2012;45:450–454.
   PubMed Web of Science ®Google Scholar
• Caimi G, Carollo C, Hopps E, et al. Protein oxidation in chronic kidney disease. Clin Hemorheol Microcirc. 2013;54:409–413.
   PubMed Web of Science ®Google Scholar
• Colombo G, Reggiani F, Cucchiari D, et al. Plasma protein carbonylation in haemodialysed patients: focus on diabetes and gender. Oxid Med Cell Longev. 2018;2018:1–12.
   Google Scholar
• Colombo G, Reggiani F, Cucchiari D, et al. Plasma protein-bound di-tyrosines as biomarkers of oxidative stress in end stage renal disease patients on maintenance haemodialysis. BBA Clin. 2017;7:55–63.
   PubMed Web of Science ®Google Scholar
• Colombo G, Reggiani F, Podestà MA, et al. Plasma protein thiolation index (PTI) as a biomarker of thiol-specific oxidative stress in haemodialyzed patients. Free Radic Biol Med. 2015;89:443–451.
   PubMed Web of Science ®Google Scholar
• Fanti P, Giustarini D, Rossi R, et al. Dietary intake of proteins and calories is inversely associated with the oxidation state of plasma thiols in end-stage renal disease patients. J Ren Nutr. 2015;25:494–503.
   PubMed Web of Science ®Google Scholar
• Capeillère-Blandin C, Gausson V, Descamps-Latscha B, et al. Biochemical and spectrophotometric significance of advanced oxidized protein products. Biochim Biophys Acta. 2004;1689:91–102.
   PubMed Web of Science ®Google Scholar
• Anderstam B, Ann-Christin BH, Valli A, et al. Modification of the oxidative stress biomarker AOPP assay: application in uremic samples. Clin Chim Acta. 2008;393:114–118.
   PubMed Web of Science ®Google Scholar
• Chen YH, Shi W, Liang XL, et al. Effect of blood sample type on the measurement of advanced oxidation protein products as a biomarker of inflammation and oxidative stress in hemodialysis patients. Biomarkers. 2011;16:129–135.
   PubMed Web of Science ®Google Scholar
• Hanasand M, Omdal R, Norheim KB, et al. Improved detection of advanced oxidation protein products in plasma. Clin Chim Acta. 2012;413:901–906.
   PubMed Web of Science ®Google Scholar
• Suvakov S, Jerotic D, Damjanovic T, et al. Markers of oxidative stress and endothelial dysfunction predict haemodialysis patients survival. Am J Nephrol. 2019;50:115–125.
   PubMed Web of Science ®Google Scholar
• Capeillère-Blandin C, Gausson V, Nguyen AT, et al. Respective role of uraemic toxins and myeloperoxidase in the uraemic state. Nephrol Dial Transplant. 2006;21:1555–1563.
   PubMed Web of Science ®Google Scholar
• Colombo G, Clerici M, Giustarini D, et al. A central role for intermolecular dityrosine cross-linking of fibrinogen in high molecular weight advanced oxidation protein product (AOPP) formation. Biochim Biophys Acta. 2015;1850:1–12.
   PubMed Web of Science ®Google Scholar
• Colombo G, Clerici M, Altomare A, et al. Thiol oxidation and di-tyrosine formation in human plasma proteins induced by inflammatory concentrations of hypochlorous acid. J Proteomics. 2017;152:22–32.
   PubMed Web of Science ®Google Scholar
• Rodríguez-Ayala E, Anderstam B, Suliman ME, et al. Enhanced RAGE-mediated NFkappaB stimulation in inflamed hemodialysis patients. Atherosclerosis. 2005;180:333–340.
   PubMed Web of Science ®Google Scholar
• Witko-Sarsat V, Descamps-Latscha B. Advanced oxidation protein products: novel uraemic toxins and pro-inflammatory mediators in chronic renal failure? Nephrol Dial Transplant. 1997;12:1310–1312.
   PubMed Web of Science ®Google Scholar
• Iwao Y, Anraku M, Hiraike M, et al. The structural and pharmacokinetic properties of oxidized human serum albumin, advanced oxidation protein products (AOPP). Drug Metab Pharmacokinet. 2006;21:140–146.
   PubMed Web of Science ®Google Scholar
• Cachofeiro V, Goicochea M, de Vinuesa SG, et al. Oxidative stress and inflammation, a link between chronic kidney disease and cardiovascular disease. Kidney Int Suppl. 2008;74:S4–S9.
   Web of Science ®Google Scholar
• Witko-Sarsat V, Gausson V, Nguyen AT, et al. AOPP-induced activation of human neutrophil and monocyte oxidative metabolism: a potential target for N-acetylcysteine treatment in dialysis patients. Kidney Int. 2003;64:82–91.
   PubMed Web of Science ®Google Scholar
• Guo ZJ, Niu HX, Hou FF, et al. Advanced oxidation protein products activate vascular endothelial cells via a RAGE-mediated signaling pathway. Antioxid Redox Signal. 2008;10:1699–1712.
   PubMed Web of Science ®Google Scholar
• Kocak H, Gumuslu S, Sahin E, et al. Advanced oxidative protein products are independently associated with endothelial function in peritoneal dialysis patients. Nephrol (Carlton). 2009;14:273–280.
   PubMed Web of Science ®Google Scholar
• Marsche G, Frank S, Hrzenjak A, et al. Plasma-advanced oxidation protein products are potent high-density lipoprotein receptor antagonists in vivo. Circ Res. 2009;104:750–757.
   PubMed Web of Science ®Google Scholar
• Zhou Q, Wu S, Jiang J, et al. Accumulation of circulating advanced oxidation protein products is an independent risk factor for ischaemic heart disease in maintenance haemodialysis patients. Nephrol (Carlton). 2012;17:642–649.
   PubMed Web of Science ®Google Scholar
• Matteucci E, Biasci E, Giampietro O. Advanced oxidation protein products in plasma: stability during storage and correlation with other clinical characteristics. Acta Diabetol. 2001;38:187–189.
   PubMed Web of Science ®Google Scholar
• Duranton F, Depner TA, Argilés À. The saga of two centuries of urea: nontoxic toxin or vice versa? Semin Nephrol. 2014;34:87–96.
   PubMed Web of Science ®Google Scholar
• Colombo G, Clerici M, Garavaglia ME, et al. A step-by-step protocol for assaying protein carbonylation in biological samples. J Chromatogr B Analyt Technol Biomed Life Sci. 2016;1019:178–190.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organization Technical Report. Geneva: WHO; 2000. p. 1–253.
   Google Scholar
• Witko-Sarsat V, Friedlander M, Capeillère-Blandin C, et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int. 1996;49:1304–1313.
   PubMed Web of Science ®Google Scholar
• Selmeci L, Székely M, Soós P, et al. Human blood plasma advanced oxidation protein products (AOPP) correlates with fibrinogen levels. Free Radic Res. 2006;40:952–958.
   PubMed Web of Science ®Google Scholar
• Selmeci L. Advanced oxidation protein products (AOPP): novel uremic toxins, or components of the non-enzymatic antioxidant system of the plasma proteome? Free Radic Res. 2011;45:1115–1123.
   PubMed Web of Science ®Google Scholar
• Liu B, Hou X, Zhou Q, et al. Detection of advanced oxidation protein products in patients with chronic kidney disease by a novel monoclonal antibody. Free Radic Res. 2011;45:662–671.
   PubMed Web of Science ®Google Scholar
• Meuwese CL, Stenvinkel P, Dekker FW, et al. Monitoring of inflammation in patients on dialysis: forewarned is forearmed. Nat Rev Nephrol. 2011;7:166–176.
   PubMed Web of Science ®Google Scholar
• Noori N, Kovesdy CP, Dukkipati R, et al. Racial and ethnic differences in mortality of hemodialysis patients: role of dietary and nutritional status and inflammation. Am J Nephrol. 2011;33:157–167.
   PubMed Web of Science ®Google Scholar
• Walther CP, Carter CW, Low CL, et al. Interdialytic creatinine change versus predialysis creatinine as indicators of nutritional status in maintenance hemodialysis. Nephrol Dial Transplant. 2012;27:771–776.
   PubMed Web of Science ®Google Scholar
• Kalantar-Zadeh K, Streja E, Molnar MZ, et al. Mortality prediction by surrogates of body composition: an examination of the obesity paradox in hemodialysis patients using composite ranking score analysis. Am J Epidemiol. 2012;175:793–803.
   PubMed Web of Science ®Google Scholar
• Rroji M, Eloot S, Dhondt A, et al. Association of advanced age with concentrations of uraemic toxins in CKD. J Nephrol. 2016;29:81–91.
   PubMed Web of Science ®Google Scholar
• Fink JC, Burdick RA, Kurth SJ, et al. Significance of serum creatinine values in new end-stage renal disease patients. Am J Kidney Dis. 1999;34:694–701.
   PubMed Web of Science ®Google Scholar
• Sehl ME, Yates FE. Kinetics of human aging: I. Rates of senescence between ages 30 and 70 years in healthy people. J Gerontol A Biol Sci Med Sci. 2001;56:B198–B208.
   PubMed Web of Science ®Google Scholar
• Kim JK, Choi SR, Choi MJ, et al. Prevalence of and factors associated with sarcopenia in elderly patients with end-stage renal disease. Clin Nutr. 2014;33:64–68.
   PubMed Web of Science ®Google Scholar
• Park J, Mehrotra R, Rhee CM, et al. Serum creatinine level, a surrogate of muscle mass, predicts mortality in peritoneal dialysis patients. Nephrol Dial Transplant. 2013;28:2146–2155.
   PubMed Web of Science ®Google Scholar
• Isoyama N, Qureshi AR, Avesani CM, et al. Comparative associations of muscle mass and muscle strength with mortality in dialysis patients. CJASN. 2014;9:1720–1728.
   PubMed Web of Science ®Google Scholar
• Ward RA, Ouseph R, McLeish KR. Effects of high-flux hemodialysis on oxidant stress. Kidney Int. 2003;63:353–359.
   PubMed Web of Science ®Google Scholar
• Fragedaki E, Nebel M, Schupp N, et al. Genomic damage and circulating AGE levels in patients undergoing daily versus standard haemodialysis. Nephrol Dial Transplant. 2005;20:1936–1943.
   PubMed Web of Science ®Google Scholar
• Kaneda H, Taguchi J, Ogasawara K, et al. Increased level of advanced oxidation protein products in patients with coronary artery disease. Atherosclerosis. 2002;162:221–225.
   PubMed Web of Science ®Google Scholar
• Coskun C, Kural A, Döventas Y, et al. Hemodialysis and protein oxidation products. Ann N Y Acad Sci. 2007;1100:404–408.
   PubMed Web of Science ®Google Scholar
• Kuchta A, Pacanis A, Kortas-Stempak B, et al. Estimation of oxidative stress markers in chronic kidney disease. Kidney Blood Press Res. 2011;34:12–19.
   PubMed Web of Science ®Google Scholar
• Valli A, Suliman ME, Meert N, et al. Overestimation of advanced oxidation protein products in uremic plasma due to presence of triglycerides and other endogenous factors. Clin Chim Acta. 2007;379:87–94.
   PubMed Web of Science ®Google Scholar
• Taylor EL, Armstrong KR, Perrett D, et al. Optimisation of an advanced oxidation protein products assay: its application to studies of oxidative stress in diabetes mellitus. Oxid Med Cell Longev. 2015;2015:1.
   Google Scholar
• Zhang Z, Yu J, Stanton RC. A method for determination of pyridine nucleotides using a single extract. Anal Biochem. 2000;285:163–167.
   PubMed Web of Science ®Google Scholar
• Tatzber F, Griebenow S, Wonisch W, et al. Dual method for the determination of peroxidase activity and total peroxides-iodide leads to a significant increase of peroxidase activity in human sera. Anal Biochem. 2003;316:147–153.
   PubMed Web of Science ®Google Scholar
• Peskin AV, Turner R, Maghzal GJ, et al. Oxidation of methionine to dehydromethionine by reactive halogen species generated by neutrophils. Biochemistry. 2009;48:10175–10182.
   PubMed Web of Science ®Google Scholar
• Torbitz VD, Bochi GV, de Carvalho JA, et al. In vitro oxidation of fibrinogen promotes functional alterations and formation of advanced oxidation protein products, an inflammation mediator. Inflammation. 2015;38:1201–1206.
   PubMed Web of Science ®Google Scholar
• Marques de Mattos A, Marino LV, Ovidio PP, et al. Protein oxidative stress and dyslipidemia in dialysis patients. Ther Apher Dial. 2012;16:68–74.
   PubMed Web of Science ®Google Scholar
• Himmelfarb J, Stenvinkel P, Ikizler TA, et al. The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int. 2002;62:1524–1538.
   PubMed Web of Science ®Google Scholar
• Massy ZA, Stenvinkel P, Drueke TB. The role of oxidative stress in chronic kidney disease. Semin Dial. 2009;22:405–408.
   PubMed Web of Science ®Google Scholar
• D’Apolito M, Du X, Zong H, et al. Urea-induced ROS generation causes insulin resistance in mice with chronic renal failure. J Clin Invest. 2010;120:203–213.
   PubMed Web of Science ®Google Scholar
• D'Apolito M, Du X, Pisanelli D, et al. Urea-induced ROS cause endothelial dysfunction in chronic renal failure. Atherosclerosis. 2015;239:393–400.
   PubMed Web of Science ®Google Scholar
• Qing Z, Ling-Ling E, Dong-Sheng W, et al. Relationship of advanced oxidative protein products in human saliva and plasma: age- and gender-related changes and stability during storage. Free Radic Res. 2012;46:1201–1206.
   PubMed Web of Science ®Google Scholar
• Sciskalska M, Zalewska M, Grzelak A, et al. The influence of the occupational exposure to heavy metals and tobacco smoke on the selected oxidative stress markers in smelters. Biol Trace Elem Res. 2014;159:59–68.
   PubMed Web of Science ®Google Scholar